CELOX PPH has significantly changed our department’s approach to managing postpartum haemorrhage (PPH), offering an effective and user-friendly addition to our treatment arsenal. Over the past year, we have utilized CELOX PPH in 30 cases: 16 during caesarean sections, 11 during vaginal deliveries, twice for bleeding control following second-trimester abortions, and once as an adjunct in managing severe intra-abdominal bleeding after a complicated peripartum hysterectomy. Remarkably, the method succeeded in all but one instance, where additional intervention with selective embolization of pelvic vessels was required. This innovative product has allowed us to further personalize treatment protocols, adapting to the unique needs of each patient. The evolution in our therapeutic strategies over the year highlights the value of CELOX PPH in enhancing patient outcomes.” –